Pfizer, Valneva to stop testing Lyme disease vaccine in some U.S. patients | Reuters
Drugmaker Pfizer Inc and France's Valneva will stop testing a Lyme disease vaccine in roughly half of U.S. patients in a late-stage study, the companies said, citing a breach of clinical trial guidelines by a third-party contractor.